Pharmaceutical Executive-10-01-2010

Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives

Health reform requires detailed tracking and full disclosure of fees to docs for marketing and research

Tracking, monitoring, and trend evaluation is not enough. Companies must now do more than assess what happened and why.

An underutilized sales resource, pharmacies and their staffs can help lead to improved scrip fulfillment and increased business

Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?

A leading industry player speaks out on what is fueling success in the sector

A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers

Ethical behavior can be a bridge-builder in an era where Big Pharma needs to find new partners. Is it up to the challenge?

Innovating in R&D may not be such a complicated task. Consumers simply want to find the product that gets a job done right every time